AzTrials
AzTrials

HypothermiaKBWNCT01425086

Clinical Performance of the Embrace Isothermal Mattress

An observational study of Hypothermia, run by Stanford University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this pilot study is to evaluate the performance of a new warming technology (Embrace Isothermal Mattress) during the thermal weaning of premature infants from incubators to open cribs. Read more about this study

Who is it for?
Ages 1 day to 120 days
Conditions the study is for
Hypothermia
What is being tested?
Embrace, PCM, warming blanket
Type of treatment
Medical device
How many people
36 participants
Where
1 siteUnited States
Study dates
Mar 2011to 31 Dec 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 120 days
  • All sexes
  • No healthy volunteers
  • Child

Study population: Low birth weight neonates

Who may be able to join

  • Prematurity (27 to 34 weeks post-menstrual age at birth, 33 to 35 weeks post-menstrual age at screening)
  • At risk for environmental hypothermia
  • Cared for in an incubator
  • Currently undergoing thermal weaning (no less than 72 hours prior to anticipated thermal weaning to transition to an open crib)
  • Cardio-respiratory stability (as determined by physician/NNP)
  • Written informed parental consent

Who cannot join

  • Continuing requirement of phototherapy
  • Continuing requirement of assisted ventilation (e.g. CPAP)
  • Cardio-respiratory instability (as determined by physician)
  • Clinically-significant congenital abnormalities (as determined by PI)
  • Acidosis or ongoing sepsis
  • Dehydration (defined by hypernatremia with serum sodium > 150 meq/L)
  • Any additional concurrent high risk medical/surgical condition (as determined by physician, NNP or PI)
  • Refusal of participation by parents -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Lucile Packard Children's Hospital

    Palo Alto, California, 94304

Other trials in United States

About this study

Official title: Clinical Performance of the Embrace Isothermal Mattress in Stabilizing Temperatures of the Preterm Infants During Thermal Weaning

The purpose of this pilot study is to evaluate the performance of a new warming technology (Embrace Isothermal Mattress) during the thermal weaning of premature infants from incubators to open cribs. The investigators aim to study the Embrace Isothermal Mattress over a 24-hour period before the infant is transitioned out of the incubator.

Read the detailed description

The investigators aim to use the results of this pilot study in preparation for a larger, longer, multi-center clinical trial testing the performance of the Embrace Isothermal Mattress during the weaning of premature infants from incubators to open cribs (thermal weaning). Specifically, this study would provide physiological data (e.g. temperature, weight) and operational experience (e.g. logistical issues, familiarity with technology) that would assess the short-term effectiveness (< 24 hours) of the new technology in maintaining temperature stability as well as informing the subsequent trial.

This study will build upon two primary bodies of scientific knowledge: (1) the applicability of an isothermal mattress as a supplemental heat source during thermal weaning and (2) basic clinical knowledge of the quality, quantity, and timing of warming during the thermal weaning process.

First, current thermal weaning processes at LPCH are heavily dependent upon prolonged use of incubators. Additional sources of warming include radiant warmers, transwarmers (e.g. one-time use gel-packs), skin-to-skin contact (e.g. Kangaroo Mother Care), and others. While all provide sufficient warming during thermal weaning but are not always ideal (e.g. incubators separate mother and baby, radiant warmer and transwarmers have varying abilities to stabilize temperature over prolonged periods, and skin-to-skin contact is not constantly available). In contrast, the Embrace Isothermal Mattress is based on a wax-like phase-change-material (PCM) that allows for an extremely stable long-term heat exchange with an infant. It was designed to function without a constant source of electricity and is relatively portable allowing for its use as a supplement to incubators, skin-to-skin contact, and other warming techniques.

Secondly, this study will inform future clinical practices specifically in thermal weaning and generally in neonatal temperature regulation. Thermal weaning occurs when the incubator's set temperature is incrementally lowered by nurses in preparation for a transition to an open crib. Eventually, a clinical decision is made to clothe the infant and turn off the incubator (based upon physiological markers and nursing experience). A period of observation of the clothed infant within the switched-off incubator (immediate to 12 hours based on a survey of LPCH nurses) then precedes transition to an open crib. A series of retrospective chart reviews has observed a range of thermal weaning practices between and within LPCH-affiliated nurseries possibly due to a wide interpretation of existing thermal weaning protocols (e.g. weaning at different post- menstrual ages, physiological characteristics, cognitive development). The investigators are hopeful that this study will provide additional scientific data to inform clinical decision-making during thermal weaning.

Ultimately, the research performed in this pilot study and subsequent clinical trial will determine whether the Embrace Isothermal Mattress may facilitate a more optimal transition of an infant from an incubator to an open crib. For example, if infants are found to transition effectively at lower body weight and post-menstrual age while still maintaining temperature stability while using the Embrace Isothermal Mattress, then clinicians can offer an alternative thermal weaning method with additional secondary benefits. Specifically, this early transition may facilitate earlier mother-child bonding and improve the infant's quality of life ultimately leading to a more advanced developmental stage upon discharge from the PICN. In addition, use of this new technology as an alternative for weaning may free incubators for more life-threatening cases, ultimately providing for more efficient and cost-effective use of PICN resources. Therefore, the end goal is to improve overall clinical practice and patient experience by introducing and evaluating a potentially beneficial warming technology.

Conditions
Hypothermia
Being tested
Embrace, PCM, warming blanket
Keywords
Incubator,, hypothermia,, preterm,, low-birthweight infants,, embrace device,, phase change materials, PCM
Medical subject headings
Hypothermia, Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Embrace, PCM, warming blanketDevice

    Also called Embrace Device, Embrace Isothermal Mattress, Embrace Blanket, PCM blanket

    Infant will be placed on a blanket that encloses the Embrace device, The infant will be wrapped in this blanket to create a snug, comfortable and warm "micro-environment".

Study groups in NCT01425086
Study groupRoleWhat they receive
Incubator temperature supportInfant will be cared for in the current ongoing policy-driven temperature support provided by the incubator and handling as per bedside nursing interventions. Infant will be followed clinically until discharge from Lucile Packard Hospital (average 4 weeks).
Receives: Device: Embrace, PCM, warming blanket
Embrace blanket warmingInfant will be placed and wrapped in the embrace blanket and cared for and monitored for temperature support and monitored by bedside nursing interventions, as needed. Infant will be followed clinically until discharge from Lucile Packard Hospital (average 4 week
Receives: Device: Embrace, PCM, warming blanket

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Temperature Stability

    As monitored by ambient (environmental) temperature, infant's core and surface temperature

    Measured: 48 hours

Secondary outcomes (1)
  1. Safety assessment by absence of change in cardio-respiratory events

    As monitored by heart rate, respiratory rates, pulse-oximetry and occurrence of apnea events

    Measured: 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2011 (estimated)
  2. Study startMar 2011
  3. Primary completion20 Dec 2012
  4. Study completion31 Dec 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01425086
Sponsor's protocol ID
SU-03222011-7607
Other IDs
eProtocol 19750
Acronym
KBW
Status last verified
Oct 2017
First submitted
24 Aug 2011
Last updated
9 Oct 2017
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Hypothermia, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Temperature Stability (time frame: 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in